[{"id":"e32ff061-efec-4127-94d5-8342bcf464d8","acronym":"","url":"https://clinicaltrials.gov/study/NCT05242822","created_at":"2022-02-16T15:53:29.200Z","updated_at":"2024-07-02T16:35:06.798Z","phase":"Phase 1","brief_title":"A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations","source_id_and_acronym":"NCT05242822","lead_sponsor":"Kinnate Biopharma","biomarkers":" FGFR2","pipe":"","alterations":" ","tags":["FGFR2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KIN-3248"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 54","initiation":"Initiation: 04/18/2022","start_date":" 04/18/2022","primary_txt":" Primary completion: 06/01/2026","primary_completion_date":" 06/01/2026","study_txt":" Completion: 09/01/2026","study_completion_date":" 09/01/2026","last_update_posted":"2024-04-30"}]